Recently a possible link between elevated Chromogranin A (CgA) levels and poorly differentiated prostate cancer has been proposed. The aim of our study was to explore the association of CgA levels and the risk of poorly differentiated prostate cancer (PCa) in men undergoing radical retropubic prostatectomy (RRP).

Serum levels of chromogranin are not predictive of poorly differentiated prostate cancer: Results from a multicenter radical prostatectomy cohort

Lombardo, Riccardo;Rovesti, Lorenzo;Cicione, Antonio;Gravina, Carmen;Franco, Antonio;Stira, Jordi;D'Annunzio, Simone;Nacchia, Antonio;Mastroianni, Riccardo;Brassetti, Aldo;Vecchione, Andrea;Gallucci, Michele;Tubaro, Andrea;De Nunzio, Cosimo
2022

Abstract

Recently a possible link between elevated Chromogranin A (CgA) levels and poorly differentiated prostate cancer has been proposed. The aim of our study was to explore the association of CgA levels and the risk of poorly differentiated prostate cancer (PCa) in men undergoing radical retropubic prostatectomy (RRP).
File allegati a questo prodotto
File Dimensione Formato  
The Prostate - 2022 - Lombardo - Serum levels of chromogranin are not predictive of poorly differentiated prostate cancer .pdf

accesso aperto

Note: Lombardo_Serum levels of chromogranin_2022
Tipologia: Documento in Post-print (versione successiva alla peer review e accettata per la pubblicazione)
Licenza: Creative commons
Dimensione 609.05 kB
Formato Adobe PDF
609.05 kB Adobe PDF Visualizza/Apri PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11573/1651823
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
social impact